Skip to content
PICO Portalanswers from OpenAlex

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

PaperCitations, authors & open-access status

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus is a paper indexed in PICO Portal from OpenAlex.

How many citations does Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus have?

PICO Portalcitation count

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus has 107 citations in the OpenAlex counts PICO Portal stores.

When was Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus published?

PICO Portalyear

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus has 2017 year in the PICO Portal index.

What is the open-access status of Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus?

PICO Portaloa status

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus has closed oa status in the PICO Portal index.

What is the DOI of Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus?

PICO Portaldoi

The DOI for Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus is on the source record.

What is the PMID of Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus?

PICO Portalpmid

The PMID for Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus is on the source record.

What is the OpenAlex record for Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus?

PICO Portalopenalex

The OpenAlex for Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial